Hyperprogressive disease in patients suffering from solid malignancies treated by immune checkpoint inhibitors: A systematic review and meta-analysis

Overview of attention for article published in Frontiers in oncology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 10 Dimensions

Readers on

mendeley: 8 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 10 publications that cite this research output.

10

The most recent citing publications are shown below. View all 10 publications that cite this research output on Dimensions.

Иммунотерапия перед трансплантацией печени: обзор литературы и клинический случай гепатоцеллюлярной карциномы с мутацией BRCA1

Article in Innovative medicine of Kuban (August 2024)

Advancements in neoadjuvant immune checkpoint inhibitor therapy for locally advanced head and neck squamous Carcinoma: A narrative review

Article in International Immunopharmacology (May 2024)

The long and winding road to biomarkers for immunotherapy: a retrospective analysis of samples from patients with triple-negative breast cancer treated with pembrolizumab

Article in ESMO Open (May 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.